+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hepatitis Drugs Markets in China

  • ID: 1022811
  • Report
  • June 2019
  • Region: China
  • 196 pages
  • AMID Co
1 of 3
China's demand for Hepatitis Drugs will continue to grow at about 8% by 2028
China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

These market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, these research reports provide the insights and projections into Chinese markets necessary for you to do so.
Note: Product cover images may vary from those shown
2 of 3
I. INTRODUCTION
Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
Hepatitis Drugs Industry Structure
Market Size
Market Growth Drivers
Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations and Sales Volumes
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
Overview
Sales Volumes of Hepatitis Drugs by Region
Hepatitis Drugs Sales Volumes
Liver Protection Drugs
Nucleoside Drugs
Interferon (IFN)
Other Hepatitis Drugs
Hepatitis Drugs Imports and Exports
Hepatitis Drugs Imports
Hepatitis Drugs Exports
Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK
Hepatitis Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES
China Market Entry Overview
China's Distribution System
Hepatitis Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. HEPATITIS DRUGS PRODUCER DIRECTORY
Hepatitis Drugs Producer Profiles

LIST OF TABLES

I. INTRODUCTION
Economic Outlook Summary

II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations
Major Hepatitis Drugs Producer Sales Volumes
Market Share of Key Producers
Major Foreign Investments in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
Hepatitis Drugs Sales Volumes
Sales Volumes of Hepatitis Drugs by Region
Major Liver Protection Drugs Producer Sales Volumes
Liver Protection Drugs Sales Volumes
Major Nucleoside Drugs Producer Sales Volumes
Nucleoside Drugs Sales Volumes
Major IFN Drugs Producer Sales Volumes
Interferon (IFN) Sales Volumes
Other Hepatitis Drugs Sales Volumes
China Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK
Total hepatitis Drugs Sales Volumes by Market
Hepatitis Drugs Sales Volumes and Market Share
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION
China’s Hepatitis Drugs Sales Volumes

II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
Hepatitis Drugs Sales Volumes in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
Total Hepatitis Drugs Sales Volumes
Total Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK
Hepatitis Drugs Sales Volumes by Market

VI. MARKETING STRATEGIES
China’s Distribution Channel
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Shenzhen Kexing Biotech Co., Ltd.
  • The United Laboratories (Zhuhai) Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll